These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35450535)

  • 1. Traumatic Brain Injury in COVID-19 Patients with the Manifestation of Paroxysmal Sympathetic Hyperactivity and Cytokine Storm.
    Sami Z; Javed A
    CNS Neurol Disord Drug Targets; 2023; 22(6):786-788. PubMed ID: 35450535
    [No Abstract]   [Full Text] [Related]  

  • 2. Sympathetic storm or Cytokine storm: A diagnostic dilemma in patient of traumatic brain injury with COVID 19.
    Singh K; Kumar N; Kumar A; Kumar A; Shaju AR
    Acta Neurol Taiwan; 2021 Jun; 30(2)():78-80. PubMed ID: 34549393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Admission Features Associated With Paroxysmal Sympathetic Hyperactivity After Traumatic Brain Injury: A Case-Control Study.
    Podell JE; Miller SS; Jaffa MN; Pajoumand M; Armahizer M; Chen H; Tripathi H; Schwartzbauer GT; Chang WW; Parikh GY; Hu P; Badjatia N
    Crit Care Med; 2021 Oct; 49(10):e989-e1000. PubMed ID: 34259439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paroxysmal Sympathetic Hyperactivity Syndrome Following Traumatic Brain Injury.
    Compton E
    Nurs Clin North Am; 2018 Sep; 53(3):459-467. PubMed ID: 30100010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate Efficacy for Agitation Management in a Patient With Paroxysmal Sympathetic Hyperactivity Due to Traumatic Brain Injury.
    Chen A; Sharoha N
    Prim Care Companion CNS Disord; 2021 Oct; 23(5):. PubMed ID: 34651470
    [No Abstract]   [Full Text] [Related]  

  • 6. Paroxysmal Sympathetic Hyperactivity After Severe Traumatic Brain Injury in Children: Prevalence, Risk Factors, and Outcome.
    Alofisan TO; Algarni YA; Alharfi IM; Miller MR; Charyk Stewart T; Fraser DD; Tijssen JA
    Pediatr Crit Care Med; 2019 Mar; 20(3):252-258. PubMed ID: 30489486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paroxysmal sympathetic hyperactivity during traumatic brain injury.
    Jafari AA; Shah M; Mirmoeeni S; Hassani MS; Nazari S; Fielder T; Godoy DA; Seifi A
    Clin Neurol Neurosurg; 2022 Jan; 212():107081. PubMed ID: 34861468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging nanomaterials applied for tackling the COVID-19 cytokine storm.
    Yang X; You J; Wei Y; Li H; Gao L; Guo Q; Huang Y; Gong C; Yi C
    J Mater Chem B; 2021 Oct; 9(39):8185-8201. PubMed ID: 34528037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What Is a Cytokine Storm and Should It Matter to Me?
    Simkin J; Strange T; Leblanc N; Rivera JC
    J Am Acad Orthop Surg; 2021 Apr; 29(7):297-299. PubMed ID: 33443384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etoposide as Salvage Therapy for Cytokine Storm Due to Coronavirus Disease 2019.
    Patel M; Dominguez E; Sacher D; Desai P; Chandar A; Bromberg M; Caricchio R; Criner GJ;
    Chest; 2021 Jan; 159(1):e7-e11. PubMed ID: 32931823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paroxysmal sympathetic hyperactivity concurrent with hypothalamic injury in a patient with intracerebral hemorrhage: A case report.
    Jang SH; Choi KH
    Medicine (Baltimore); 2022 Aug; 101(32):e30058. PubMed ID: 35960042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
    Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
    Front Immunol; 2021; 12():749291. PubMed ID: 34867978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Paroxysmal sympathetic hyperactivity].
    Corell A; Ljungqvist J
    Lakartidningen; 2021 Dec; 118():. PubMed ID: 34914088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis?
    Liu JM; Chi J
    Exp Biol Med (Maywood); 2022 Feb; 247(4):330-337. PubMed ID: 35068219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy Between Cytokines and Risk Factors in the Cytokine Storm of COVID-19: Does Ongoing Use of Cytokine Inhibitors Have a Protective Effect?
    Miossec P
    Arthritis Rheumatol; 2020 Dec; 72(12):1963-1966. PubMed ID: 32725790
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of cytokine storm on severity of COVID-19 disease in a private hospital in West Jakarta prior to vaccination.
    Ramatillah DL; Gan SH; Pratiwy I; Syed Sulaiman SA; Jaber AAS; Jusnita N; Lukas S; Abu Bakar U
    PLoS One; 2022; 17(1):e0262438. PubMed ID: 35077495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emergence of a new cytokine storm during the COVID-19 pandemic: Multisystem inflammatory syndrome in children.
    Yang MC; Tsai CC; Su YT; Wu JR
    Kaohsiung J Med Sci; 2021 Mar; 37(3):255-256. PubMed ID: 33400372
    [No Abstract]   [Full Text] [Related]  

  • 19. Spasticity management and resolution of paroxysmal sympathetic hyperactivity in the acute care setting: a case series.
    Edmond A; McKay O; Mehta N; Dabaghian L; Yonclas P
    Brain Inj; 2022 May; 36(6):817-821. PubMed ID: 35608189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Medical Complications During the Rehabilitation of Moderate-Severe Traumatic Brain Injury.
    Schultz BA; Bellamkonda E
    Phys Med Rehabil Clin N Am; 2017 May; 28(2):259-270. PubMed ID: 28390512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.